Skip to Main Content

Paper Details

Corrigendum to "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)".
EBioMedicine
1
2023
Author NameAffiliation
Rafael DelgadoHospital Universitario 12 de Octubre - Imas12
Jos?? R ArribasHospital Universitario La Paz - IdiPAZ. Paseo de la Castellana 261
  • 1 - 2

Datasets

Release 1.2